BIOS Fund II QP, LP has filed 4 Form 4s with the SEC that we hold, for In8Bio, INC. (INAB) (10% owner), Actuate Therapeutics, INC. (ACTU) (Director, 10% owner) and Lantern Pharma Inc. (LTRN) (10% owner). Across all of them we count 8 purchases worth $4.1M and 8 sales worth $348.6K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 375,000 shares of Actuate Therapeutics, INC. worth $3.0M, dated 2024-08-14. The first filing on our record is dated 2022-08-30 and the latest 2025-06-13.
Counted from the Form 4 filings
this reporting owner (SEC CIK 1716869) filed on EDGAR. Values are the transaction values
as filed. See every filing on EDGAR,
or browse insider buying and
today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-28 ·
For informational purposes only, not investment advice. Privacy · Terms
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.
